Inactive

See attached RFP in MS word and PDF format ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ The purpose of this Amendment 00001 is to do the following: 1. Provide answers to ALL questions submitted by offerors. See... See attached RFP in MS word and PDF format ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ The purpose of this Amendment 00001 is to do the following: 1. Provide answers to ALL questions submitted by offerors. See the Question and Answer attachment in PDF format. 2. Based on the answers to questions, post a revised copy of Solicitation No. 75D301-22-R-72191. See attached revised documents. 2. As a result of this amendment 00001, the receipt date for proposals is not extended. Proposals are due no later than 2:00PM EST on Friday, May 20, 2022. Offerors are to acknowledge receipt of this Amendment 00001 with proposal submission. See Block 14 on page 1 of the Solicitation and Block 11 of the attached Amendment 00001.

Inactive

The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) has a requirement for a contract to estimate the value to the heal... The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) has a requirement for a contract to estimate the value to the healthcare system and society of clinical care-based interventions that improve performance measures across the LTBI care cascade. The interventions are funded through contracts with four different TBESC-III sites, which focus on increasing identification of persons at high risk for LTBI, increasing testing with recommended diagnostics, and ensuring treatment of LTBI among non-U.S.–born persons in U.S. primary care settings. The contractor shall hold primary responsibility for ensuring the completion of the TBESC-III cost-effectiveness analysis. The contractor shall review the effectiveness and cost data submitted to CDC by TBESC-III sites, and design and carryout the cost-effectiveness analyses in collaboration with the TBESC-III sitesThe study requires the contractor to implement an LTBI targeted testing and treatment program at their respective institution(s) in a primary healthcare setting. The contractor shall collect and provide CDC-specified data elements, including deidentified patient-level data. This requirement will be solicited as a FULL and OPEN Competition. It will use NAICS code 541690 – Other Scientific and Technical Consulting Services with a small business size standard of $16.5 Million. Any incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-05, effective March 7, 2022. The CDC anticipates a Time and Materials contract with a 48-month period of performance. The complete solicitation document, and reference material, if applicable, is anticipated to be available for downloading at SAM.gov on or about April 11, 2022 and proposals are anticipated to be due on or about May 10,2022. No verbal or written requests for copies will be accepted. To be eligible to receive an award resulting from this solicitation, the contractor must be registered in the System for Award Management (SAM). To register, apply via the Internet at http://www.sam.gov. For questions on registration contact Federal Service Desk at 866-606-8220. Contractors are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback with respect to any information submitted. RESPONSES TO THIS NOTICE WILL NOT BE CONSIDERED ADEQUATE RESPONSES TO A SOLICITATION.